Enhanced interferon-γ secretion and antitumor activity of T-lymphocytes activated by dendritic cells loaded with glycoengineered myeloma antigens

Chinese Medical Journal

Volumn 120, Issue 19, 2007, Pages 1678-1684

  Xiong, Hong ^a,e   Wu, Qiu Ye ^b   Hu, Hong Gang ^b   Liu, Ban ^a,e   Guo, Zhong Wu ^c   Sze, Daniel Man Yuan ^d   Hou, Jian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c WAYNE STATE UNIVERSITY   (United States)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e TONGJI UNIVERSITY   (China)

Author keywords

Dendritic cells; Immunotherapy; Multiple myeloma; T lymphocytes

Indexed keywords

CARBOHYDRATE ANTIGEN; CELL SURFACE MARKER; GAMMA INTERFERON; LACTATE DEHYDROGENASE; MANNOSAMINE; MEMBRANE ANTIGEN; SIALOGLYCOPROTEIN; TUMOR ANTIGEN;

ANTIGENICITY; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; METABOLIC ENGINEERING; MULTIPLE MYELOMA; MYELOMA CELL; PROTEIN EXPRESSION;

EID: 35348956960     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200710010-00007     Document Type: Article

References (27)

1. Dalton WS, Bergsagel PL, Kuehl WM, Anderson KC. Multiple myeloma. Hematology (Am Soc Hematol Educ Program) 2001; 157-177.
2. Chen CH, Wu TC. Experimental vaccine strategies for cancer immunotherapy. J Biomed Sci 1998; 5: 231-252.
3. Mahal LK, Bertozzi CR. Engineered cell surfaces: fertile ground for molecular landscaping. Chem Biol 1997; 4: 415-422.
4. Keppler OT, Stehling P, Herrmann M, Kayser H, Grunow D, Reutter W, et al. Biosynthetic modulation of sialic acid-dependent virus-receptor interactions of two primate polyoma viruses. J Biol Chem 1995; 270: 1308-1314.
5. Luchansky SJ, Goon S, Bertozzi CR. Expanding the diversity of unnatural cell-surface sialic acids. Chem Biol Chem 2004; 5: 371-374.
6. Tangvoranuntakul P, Gagneux P, Diaz S, Bardor M, Varki N, Varki A, et al. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci USA 2003; 100: 12045-12050.
7. Liu T, Guo Z, Yang Q, Sad S, Jennings HJ. Biochemical engineering of surface α2-8 polysialic acid for immuneotargeting tumor cells. J Biol Chem 2000; 275: 32832-32936.
8. Zou W, Borrelli S, Gilbert M, Liu T, Pon RA, Jennings HJ. Bioengineering of surface GD3 ganglioside for immunotargeting human melanoma cells. J Biol Chem 2004; 279: 25390-25399.
9. Chefalo P, Pan YB, Nagy N, Harding CV, Guo Z. Preparation and immunological studies of protein conjugates of N-acylneuraminic Acids. Glycoconj J 2004; 20: 407-414.
10. Pan Y, Chefalo P, Nagy N, Harding C, Guo Z. Synthesis and immunological properties of N-Modified GM3 as therapeutic cancer vaccines. J Med Chem 2005; 48: 875-884.
11. Ritter G, Boosfeld E, Asluri S, Calves MJ, Oettgen HF, Old LJ, et al. Antibody response after immunization with ganglioside GD3, GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma. Int J Cancer 1991; 48: 379-385.
12. Zhang ZN. Diagnosis and therapeutic effect criteria of hematological diseases. Multiple myeloma. Tianjin: Tianjin Science and Technololgy Publishing House; 1991: 303-309.
13. + T-lymphocytes according to IFN-gamma secretion for adjuvant immunotherapy. Exp Hematol 2004; 32: 282-289.
14. Hou J, Xiong H, Gao WR, Jiang H. 2-Methoxyestradiol at low dose induces differentiation of myeloma cells. Leuk Res 2005; 29: 1059-1067.
15. Castiglioni P, Martin-Fontecha A, Milan G, Tomajer V, Magni F, Michaelsson J, et al. Apoptosis-dependent subversion of the T-lymphocyte epitope hierarchy in lymphoma cells. Cancer Res 2002; 62: 1116-1122.
16. Krug LM, Ragupathi G, Ng KK, Hood C, Jennings HJ, Guo Z, et al. Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin. Clin Cancer Res 2004; 10: 916-923.
17. Guevara-Patino JA, Turk MJ, Wolchok JD, Houghton AN. Immunity to cancer through immune recognition of altered self: studies with melanoma. Adv Cancer Res 2003; 90: 157-177.
18. Raje N, Hideshima T, Davies FE, Chauhan D, Treon SP, Yong G, et al. Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma. Br J Haematol 2004; 125: 343-352.
19. Coombes BK, Mahony JB. Dendritic cell discoveries provide new insight into the cellular immunobiology of DNA vaccines. Immunol Lett 2001; 78: 103-111.
20. Nguyen XD, Eichler H, Dugrillon A, Piechaczek C, Braun M, Kluter H. Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells. J Immunol Methods 2003; 275: 57-68.
21. Matsuda K, Tsunoda T, Tanaka H, Umano Y, Tanimura H, Nukava I, et al. Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide-pulsed dendritic cells. Cancer Immunol Immunother 2004; 53: 609-616.
22. Della Bella S, Nicola S, Riva A, Biasin M, Clerici M, Willa ML. Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-alpha. J Leukoc Biol 2004; 75: 106-116.
23. + T cell responses induced by dentritic cells generated in the presence of IFN-alpha. J Immunol 2004; 172: 7832-7840.
24. Takahashi T, Makiguchi Y, Hinoda Y, Kakiuchi H, Nakagawa N, Imai K, et al. Expression of MUC1 on myeloma cells and induction of HLA-unrestricted-CTL against MUC1 from a multiple myeloma patient. J Immunol 1994; 153: 2102-2109.
25. Lauzurica P, Sancho D, Torres M, Albella B, Marazuela M, Merino T, et al. Phenotypic and functional characteristics of hematopoietic cell lineages in CD692 deficient mice. Blood 2000; 95: 2312-2320.
26. Kokhaei P, Choudhury A, Mahdian R, Lundin J, Moshfegh A, Osterborg A, et al. Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL. Leukemia 2004; 18: 1810-1815.
27. Livingston PO, Ragupathi G, Musselli C. Autoimmune and antitumor consequences of antibodies against antigens shared by normal and malignant tissues. J Clin Immunol 2000; 20: 85-93.